Regulatory submissions for generic drugs and biosimilar are essential processes in obtaining regulatory approval to market these products. While both categories aim to provide cost-effective alternatives to brand-name drugs, the regulatory requirements for generic drugs and biosimilar differ due to the complexity and nature of the products. This article provides an overview of the regulatory […]

The post Regulatory submissions for generic drugs and biosimilar appeared first on Daily 2 Daily News.

from Daily 2 Daily News https://ift.tt/4B3xkpQ
via Daily 2 Daily News